Author/Authors :
Miguel A. Sierra، نويسنده , , Mamen Rodr?guez-Fern?ndez، نويسنده , , Mar?a José Manche?o، نويسنده , , Luis Casarrubios، نويسنده , , Mar G?mez-Gallego، نويسنده ,
Abstract :
A new approach to N1–C3 bridged macrocyclic β-lactams has been developed. Orthogonal functional groupsʹ protection combined with RCM has allowed the construction of the bicyclic systems bearing a β-lactam motif. These systems could represent a structural alternative to the actual lactamic antibiotics and may be further transformed into a broad variety of compounds.